Related Experiment Videos
Summary
Metandrenolone did not cause chromosomal damage in mouse bone marrow cells. However, it induced dominant lethal mutations in male mice's early spermatids and spermatocytes, increasing early and later embryo lethality.
Area of Science:
- Toxicology
- Genetics
- Reproductive Toxicology
Background:
- Metandrenolone is an anabolic-androgenic steroid.
- Assessing the genotoxic and mutagenic potential of anabolic steroids is crucial for understanding their reproductive health risks.
Purpose of the Study:
- To evaluate the clastogenic and mutagenic effects of Metandrenolone in male mice.
- To determine if Metandrenolone induces chromosomal aberrations or dominant lethal mutations.
Main Methods:
- Male mice were administered Metandrenolone.
- Bone marrow cells were analyzed for chromosomal aberrations.
- Sexual cells (early spermatids and spermatocytes) were assessed for dominant lethal mutations by examining preimplantation and postimplantation lethality in females mated with treated males.
Main Results:
- Metandrenolone did not induce chromosomal aberrations in bone marrow cells.
- A significant increase in preimplantation lethality was observed at weeks 3, 4, and 5 post-treatment.
- Postimplantation embryonic lethality was elevated at weeks 3, 5, and 6 post-treatment, indicating dominant lethal mutations.
Conclusions:
- Metandrenolone is not clastogenic in mouse bone marrow.
- Metandrenolone exhibits mutagenic activity, specifically inducing dominant lethal mutations in male germ cells at specific developmental stages.
- The findings highlight the reproductive toxicity of Metandrenolone, particularly its impact on male fertility and embryonic development.